Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GluA1-flip isoform is a splice variant of the GluA1 subunit of AMPA receptors, which mediate fast excitatory neurotransmission. The flip/flop alternative splicing event results in protein variants with distinct functional properties, affecting glutamate sensitivity, desensitization kinetics, and network excitability. Modulation of RNA splicing toward reducing GluA1-flip expression may offer a therapeutic approach for conditions like epilepsy.
Modulation of GluA1 pre-mRNA splicing to alter the ratio of GluA1-flip to GluA1-flop isoforms, influencing AMPAR channel kinetics and neuronal excitability.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA splicing modulation of GluA1-flip isoform.